Skip to content

Left Ventricular Free-wall Ruptrue After Acute Myocardial Infarction (LVFR-AMI)

Clinical Characteristics of Left Ventricular Free-wall Ruptrue After Acute Myocardial Infarction

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04172168
Enrollment
17568
Registered
2019-11-21
Start date
2011-01-01
Completion date
2021-03-31
Last updated
2021-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Keywords

Left Ventricular Free-wall Ruptrue, Acute myocardial infarction, Coronary angiography

Brief summary

The Left Ventricular Free-wall Ruptrue (LVFR) is a serious complication caused high mortality.

Detailed description

The actual mortality of LVFR is close to 100%. Despite the mortality rate for LVFR has been decreasing with the development of reperfusion therapy, the serious complication remains a difficult challenge. The coronary anatomy distribution associated with LVFR has an interesting phenomenon. From the perspective of different coronary distribution, we can better known the risk factors related to LVFR.

Interventions

DIAGNOSTIC_TESTHeart rupture

Left ventricular free-wall ruptrue after AMI

Sponsors

Xiamen Cardiovascular Hospital, Xiamen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients be admitted for acute myocardial infarction (STEMI or NSTEMI)

Exclusion criteria

* Non-cardiovascular comorbidity for AMI

Design outcomes

Primary

MeasureTime frameDescription
Rate of heart ruputreMortality 30 daysLeft Ventricular Free-wall Ruptrue

Secondary

MeasureTime frameDescription
Rate of cardiogenic shockHospitalization 30 daysCardiogenic shock After AMI
Rate of cardiac arrestHospitalization 30 daysCardiac arrest After AMI

Countries

China

Contacts

Primary ContactYan Wang, PhD
wy@medmail.com.cn+8613860488088
Backup ContactBin Wang, PhD
mocw361@163.com+8613400664305

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026